Transfusion medicine

Recent Updates

Published:

Jan 17, 2019

Vein to Vein: A Summary of the Blood System in Canada

Chapter 1

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients.

Modified on:

Feb 26, 2019

Twitter Facebook LinkedIn Forward

Transfusion-related acute lung injury (TRALI)

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute lung injury (ALI) during or within six hours after blood product administration in the absence of temporally-associated risk factors for ALI. All plasma-containing blood products have been implicated in TRALI, including rare reports with IVIg and cryoprecipitate.

Twitter Facebook LinkedIn Forward

Published:

Aug 10, 2018

Immune Globulin Products

Chapter 4

Immune globulin (Ig) products are generated from plasma collected from a large number of carefully screened donors. Ig products may be used as replacement therapy for immunodeficiency patients or as immunomodulatory therapy for autoimmune and alloimmune disorders. Ig products include intravenous Ig (IVIg), subcutaneous Ig (SCIg), RhD Ig (RhIg) and hyperimmune globulins.

Upcoming Events

U of T Rounds: “Can antifibrinolytics prevent bleeding in patients undergoing autologous transplantation?”

Twitter Facebook LinkedIn Forward

When

March 28, 2019 | 12:00PM to 1:00PM

Where

Toronto/Webinar

Presented by:

Dawn Maze, MD, FRCPC, MSc
Division of Medical Oncology and Hematology, PMH
Assistant Professor, University of Toronto

Learning Objectives:

1. To review the evidence for prophylactic platelet transfusions in patients with hematologic malignancies.
2. To discuss the potential role of tranexamic acid to reduce bleeding and the need for platelet transfusions.
3. To present an ongoing Canadian pilot study of tranexamic acid vs. platelet transfusions in patients undergoing autologous transplantation.

Topic Teaching: Performing audits, gap analysis, root cause analysis in Transfusion Medicine/Blood Bank. How to deal with validations in TM lab.

Twitter Facebook LinkedIn Forward

When

April 2, 2019 | 12:00PM to 1:00PM

Where

Toronto/Webinar

More details to follow

Journal Club

Twitter Facebook LinkedIn Forward

When

April 9, 2019 | 12:00PM to 1:00PM

Where

Toronto/Webinar

More details to follow.

Blog

Modified on:

Mar 7, 2019

Twitter Facebook LinkedIn Forward

Pathogen Inactivation – A Primer

This primer is part I of our new series exploring the future of blood banking. Given that D is also for Development: Canadian Blood Services and the Centre for Innovation have been following the development of pathogen inactivation technologies and how they can be used to improve safety. Read-on to learn more about these technologies and their potential to shift the blood safety paradigm.

Modified on:

Feb 27, 2019

Twitter Facebook LinkedIn Forward

Research Unit: Modelling risk to ensure safety when considering changes to blood testing

This month’s Research Unit describes efforts by researchers to create a simulation and modelling study to understand how the risk of transfusion-transmission of HTLV would change if the screening were modified.

Modified on:

Feb 21, 2019

Twitter Facebook LinkedIn Forward

D is also for Development!

Welcome to our new R.E.D. blog series where we focus on our Centre for Innovation development projects to give you a glimpse into the future of blood banking... our future!